Bionano Genomics Equity Warrants Exp 21 Sep 2023 *W EXP 09/21/2023
Change company Symbol lookup
Select an option...
BNGOW Bionano Genomics Equity Warrants Exp 21 Sep 2023 *W EXP 09/21/2023
CVR Chicago Rivet & Machine Co
T AT&T Inc
HOMB Home BancShares Inc
ALG Alamo Group Inc
MGNX MacroGenics Inc
PSEC Prospect Capital Corp
SPEC Spectralcast Inc
RC Ready Capital Corp

Health Care : Life Sciences Tools & Services | Small Cap Blend
Company profile

Bionano Genomics, Inc. is a genomics company, which provides optical genome mapping (OGM) for genome analysis. The Company offers diagnostic services to physicians specializing in medical management for individuals with genetic conditions, such as pediatric neurodevelopmental disorders, including autism spectrum disorders. It markets and sell the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation. Its Lineagen business provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, it offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view.

Closing Price
Day's Change
-0.0312 (-10.06%)
B/A Size
Day's High
Day's Low

10-day average volume:

Ford stock seesaws lower as April sales drop, with weak truck sales offseting gains in SUVs, Electrified

11:22 am ET May 4, 2022 (MarketWatch)

Shares of Ford Motor Co. (F) seesawed to a 1.0% decline in morning trading Wednesday, after the automaker reported a double-digit drop in auto sales for April, with increases in SUV and electrified sales not enough to offset a big drop in trucks. The stock reversed an early decline of as much as 1.2% to trade up 0.3% intraday before turning back down. Total U.S. sales fell 10.5% to 176,965 vehicles, with trucks down 17.8% to 79,768, SUVs up 2.7% to 92,809 and electrified up 50.2% to 16,779. Electrified sales represented 9.5% of total sales. Within trucks, F-Series sales tumbled 22.3% to 51,517 trucks, while SUVs were bolstered by a 40.4% jump in Edge sales to 11,298, helping offset a 23.1% drop in Explorer sales to 20,801. Within Electrified, Mustang Mach-E sales ran up 95.0% to 3,805 vehicles, while overall Mustang sales sank 45.3% to 4,377. "While industry semiconductor chip shortages persist, improved inventory flow in April delivered a significant share gain of 1.0 percentage point over a year ago with Ford outperforming the industry," said Andrew Frick, vice president of sales in distribution and trucks. The stock had tumbled 30.6% year to date, while shares of rival General Motors Co. (GM) have plunged 32.7% and the S&P 500 has lost 12.8%.

-Tomi Kilgore


(END) Dow Jones Newswires

May 04, 2022 11:22 ET (15:22 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.